{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:41:56Z","timestamp":1778157716701,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.brachy.2012.10.005","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T05:32:32Z","timestamp":1362115952000},"page":"248-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer"],"prefix":"10.1016","volume":"12","author":[{"given":"Malolan S.","family":"Rajagopalan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeta","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Houser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2012.10.005_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11864-002-0058-4","article-title":"Vaginal cancer","volume":"3","author":"Grigsby","year":"2002","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1995.1008","article-title":"A 30-year experience in the management of primary carcinoma of the vagina: Analysis of prognostic factors and treatment modalities","volume":"56","author":"Stock","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-717X-3-7","article-title":"High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina","volume":"3","author":"Beriwal","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2005.10.007","article-title":"Radiotherapy for the treatment of primary vaginal cancer","volume":"77","author":"Samant","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/IGC.0b013e3181a12e1d","article-title":"Indiana University experience in the management of vaginal cancer","volume":"19","author":"Sinha","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2012.10.005_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1997.4752","article-title":"Isolated vaginal recurrences in endometrial carcinoma: Treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy","volume":"66","author":"Pai","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2005.11.004","article-title":"Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence","volume":"101","author":"Petignat","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brachy.2011.05.005","article-title":"3D image-based HDR interstitial brachytherapy for vaginal cancer","volume":"11","author":"Beriwal","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.10.005_bib9","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ijrobp.2011.03.049","article-title":"Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: Dose-volume parameters and first clinical results","volume":"82","author":"Dimopoulos","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.005_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brachy.2011.06.008","article-title":"American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer","volume":"11","author":"Beriwal","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.10.005_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.10.005_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.10.005_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.10.005_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brachy.2010.05.007","article-title":"High-dose rate brachytherapy in the treatment of penile carcinoma\u2014First experience","volume":"10","author":"Petera","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.10.005_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brachy.2009.05.005","article-title":"Penile brachytherapy: Technical aspects and postimplant issues","volume":"9","author":"Crook","year":"2010","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847211300189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847211300189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:06:52Z","timestamp":1761530812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153847211300189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S153847211300189X"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2012.10.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2012.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}